Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.

[1]  S. Hill,et al.  Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2 , 2018, International journal of molecular sciences.

[2]  P. Gibbs,et al.  Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes , 2017, European journal of cancer.

[3]  E. Scarpi,et al.  Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy , 2017, International journal of molecular sciences.

[4]  S. Kopetz,et al.  Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  Giovanni Simone,et al.  Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer1 , 2016, Translational oncology.

[6]  H. Clevers,et al.  TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype , 2016, EMBO molecular medicine.

[7]  N. Yuldasheva,et al.  VEGF-A isoforms program differential VEGFR2 signal transduction, trafficking and proteolysis , 2016, Biology Open.

[8]  A. Harris,et al.  Blood vessels and cancer much more than just angiogenesis , 2015, Cell Death Discovery.

[9]  M. Dimopoulos,et al.  Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer. , 2014, Clinical breast cancer.

[10]  P. Carmeliet,et al.  Markers of response for the antiangiogenic agent bevacizumab. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Tomlinson,et al.  Licensee Oa Publishing London 2013. Creative Commons Attribution Licence (cc-by) Vascular Endothelial Growth Factor-a Regulation of Blood Vessel Sprouting in Health and Disease , 2022 .

[12]  P. Catalano,et al.  Association between VEGF Splice Isoforms and Progression-Free Survival in Metastatic Colorectal Cancer Patients Treated with Bevacizumab , 2012, Clinical Cancer Research.

[13]  H. Dvorak,et al.  Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets , 2012, Clinical & Experimental Metastasis.

[14]  G. Pagès,et al.  VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy , 2011, Journal of nucleic acids.

[15]  Andigoni Malousi,et al.  Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics , 2009, PloS one.

[16]  S. Harper,et al.  Molecular Diversity of VEGF‐A as a Regulator of Its Biological Activity , 2009, Microcirculation.

[17]  M. Ladomery,et al.  Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors , 2008, Journal of Cell Science.

[18]  Gabriele Bergers,et al.  Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.

[19]  E. Kleinerman,et al.  The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice , 2008, British Journal of Cancer.

[20]  J. Folkman.  Opinion: Angiogenesis: an organizing principle for drug discovery? , 2007, Nature Reviews Drug Discovery.

[21]  G. Neufeld,et al.  Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGF* , 2000, The Journal of Biological Chemistry.

[22]  G. Neufeld,et al.  VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix* , 1997, The Journal of Biological Chemistry.

[23]  B. Jung,et al.  Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer. , 2017, Gastroenterology.

[24]  G. Pagès,et al.  VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing. , 2015, Methods in molecular biology.